AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kigelia P 1500mcg/75mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Advance Revive

Salt Composition

Methylcobalamin (1500mcg) + Pregabalin (75mg)

Overview Kigelia P 1500mcg/75mg Tablet SR

Kigelia P 1500mcg/75mg Extended-Release tablets are a prescription medication managing neuropathic pain. Its mechanism involves modulating nerve cell calcium channel activity, thus reducing pain perception. This medication also promotes nerve fiber preservation and the repair of damaged nerve cells. Administered orally, Kigelia P can be taken with or without food, ideally before sleep, at the same time daily for consistent blood levels. Adhere strictly to your doctor's prescribed dosage and duration, as this medication has a potential for dependence. Missed doses should be taken promptly upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation is discouraged; consult your physician before stopping. Commonly reported side effects include upper respiratory infection, increased appetite, elevated mood, tremors, blurred vision, dry mouth, dizziness, and somnolence. Avoid activities demanding concentration until the medication's effects are understood. Side effects are generally mild and improve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose all other medications to your doctor, as interactions may affect Kigelia P's efficacy or action. Inform your physician if you are pregnant, planning pregnancy, or breastfeeding.

Uses of Kigelia P 1500mcg/75mg Tablet SR

Managing neuropathic pain

Major Benefits of Kigelia P 1500mcg/75mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kigelia P 1500mcg/75mg Sustained-Release Tablet can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Kigelia P 1500mcg/75mg Tablet SR:

  • Sleepiness
  • Dizziness
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Increased appetite
  • Blurred vision
  • Constipation
  • Muscle cramp
  • Edema (swelling)
  • Erectile dysfunction
  • Weight gain
  • Balance disorder (loss of balance)
  • Lethargy
  • Vertigo
  • Vomiting
  • Headache
  • Confusion
  • Disorientation
  • Abnormality of voluntary movements

How to use Kigelia P 1500mcg/75mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kigelia P 1500mcg/75mg Sustained-Release Tablet can be consumed with or without food, though consistent timing is recommended.

How Kigelia P 1500mcg/75mg Tablet SR works:

Kigelia P, a 1500mcg/75mg sustained-release tablet, unites methylcobalamin and pregabalin to address neuropathic pain. Methylcobalamin, a B vitamin variant, fosters myelin production, shielding nerve fibers and aiding damaged nerve cell recovery. Pregabalin, acting as an alpha-2-delta ligand, modulates nerve cell calcium channels, thereby reducing pain perception. This synergistic effect provides relief from the discomfort of nerve damage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Kigelia P 1500mcg/75mg sustained-release tablets and alcohol may induce significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Kigelia P 1500mcg/75mg Extended-Release tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Kigelia P 1500mcg/75mg SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Kigelia P 1500mcg/75mg Extended-Release Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Kigelia P 1500mcg/75mg sustained-release tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

Patients with liver disease can likely use Kigelia P 1500mcg/75mg Tablet SR safely. Preliminary findings indicate dose modification might be unnecessary. However, physician consultation is recommended.

What if you forget to take Kigelia P 1500mcg/75mg Tablet SR :

Should you forget a Kigelia P 1500mcg/75mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Kigelia P 1500mcg/75mg Tablet SR

LabelValue
Addictive None.
Medication Classification Nervous system medication

FAQs on Kigelia P 1500mcg/75mg Tablet SR

Pregabalin and methylcobalamin, combined as Kigelia P 1500mcg/75mg SR tablets, offer relief from neuropathic pain. The medication soothes hyperactive or injured nerves by influencing brain activity, thus reducing pain perception. Additionally, it promotes the repair of damaged nerves.
Discontinuing Kigelia P 1500mcg/75mg Tablet SR, even with pain relief, is inadvisable. Follow your physician's instructions for its use. Abrupt cessation may lead to adverse effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual reduction in Kigelia P 1500mcg/75mg Tablet SR dosage is recommended prior to complete discontinuation.
Kigelia P 1500mcg/75mg Extended-Release tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Proactive weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging meal portions. Restrict high-calorie foods like sugary drinks, fried foods, processed snacks, pastries, and confectionery. Between meals, opt for fruits, vegetables, and low-calorie alternatives instead of unhealthy snacks. Regular physical activity aids in preventing weight gain. Consistent healthy eating and exercise may mitigate weight increase.
Kigelia P 1500mcg/75mg SR tablets can induce drowsiness or cause sudden sleep onset during routine tasks. This may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until the medication's effects are understood. Report any such incidents to your physician while using this medication.
Kigelia P 1500mcg/75mg Tablet SR rarely produces severe adverse reactions. Nonetheless, serious side effects such as allergic responses, suicidal ideation, or limb edema (hands, feet, or legs) are possible. Discontinue Kigelia P 1500mcg/75mg Tablet SR and seek immediate medical attention if any of these occur. Allergic reactions manifest as facial, oral, lip, gum, tongue, or neck swelling; respiratory distress; skin rashes; urticaria (wheals); or blisters. Monitor for any abrupt shifts in mood, behavior, thinking, or emotion, including the emergence of suicidal thoughts.
Patients may observe initial improvements with Kigelia P 1500mcg/75mg Tablet SR within two weeks. Complete therapeutic effects, however, might require two to three months, or longer in certain individuals.
Should you miss a scheduled dose of Kigelia P 1500mcg/75mg Tablet SR, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If, however, sufficient time remains before your next dose, take the medication immediately upon recollection, then resume your usual dosing regimen. Avoid doubling up on doses to compensate for a missed one, as this could heighten the likelihood of adverse reactions. For any uncertainty regarding missed doses, seek guidance from your physician.
Increasing the prescribed dosage of medication won't necessarily improve its effectiveness; instead, it could heighten the risk of severe adverse reactions and toxicity. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Avoid alcohol consumption while using Kigelia P 1500mcg/75mg Tablet SR. Alcohol may worsen the sleepiness this medication can cause.
Routine check-ups with your physician may be necessary following commencement of Kigelia P 1500mcg/75mg Tablet SR. Consult your doctor immediately if your symptoms persist despite adhering to the prescribed dosage, or if you encounter adverse reactions impacting your daily life.
Protect your medication by leaving it in its original packaging until needed. Store the tablets in a cool, dry location, inaccessible to children. Proper disposal of any leftover medication is crucial to prevent accidental ingestion by children, pets, or others.
Kigelia P 1500mcg/75mg Ta...
117
MRP 143
18% off